Pharmacological inhibition of coronary restenosis: systemic and local approaches
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Pharmacological inhibition of coronary restenosis: systemic and local approaches
Authors
Keywords
-
Journal
EXPERT OPINION ON PHARMACOTHERAPY
Volume 15, Issue 15, Pages 2155-2171
Publisher
Informa Healthcare
Online
2014-08-22
DOI
10.1517/14656566.2014.948844
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Publication of Trials Funded by the National Heart, Lung, and Blood Institute
- (2014) NEW ENGLAND JOURNAL OF MEDICINE
- A multicenter randomized comparison of paclitaxel-coated balloon catheter with conventional balloon angioplasty in patients with bare-metal stent restenosis and drug-eluting stent restenosis
- (2013) Seiji Habara et al. AMERICAN HEART JOURNAL
- Comparison of Dual Versus Triple Antiplatelet Therapy After Drug-Eluting Stent According to Stent Length (from the Pooled Analysis of DECLARE Trials)
- (2013) Seung-Whan Lee et al. AMERICAN JOURNAL OF CARDIOLOGY
- Systematic Review of Effectiveness of Oral Sirolimus After Bare-Metal Stenting of Coronary Arteries for Prevention of In-Stent Restenosis
- (2013) Tarun W. Dasari et al. AMERICAN JOURNAL OF CARDIOLOGY
- Comparison of Cost-Effectiveness of Oral Rapamycin Plus Bare-Metal Stents Versus First Generation of Drug-Eluting Stents (from the Randomized Oral Rapamycin in Argentina [ORAR] 3 Trial)
- (2013) Alfredo E. Rodriguez et al. AMERICAN JOURNAL OF CARDIOLOGY
- Pathology of Second-Generation Everolimus-Eluting Stents Versus First-Generation Sirolimus- and Paclitaxel-Eluting Stents in Humans
- (2013) Fumiyuki Otsuka et al. CIRCULATION
- Long-term clinical follow-up of the multicentre, randomized study to test immunosuppressive therapy with oral prednisone for the prevention of restenosis after percutaneous coronary interventions: Cortisone plus BMS or DES veRsus BMS alone to EliminAte Restenosis (CEREA-DES)
- (2013) F. Ribichini et al. EUROPEAN HEART JOURNAL
- Adjunctive Cilostazol Versus Double-Dose Clopidogrel After Drug-Eluting Stent Implantation
- (2013) Kyung Woo Park et al. JACC-Cardiovascular Interventions
- Colchicine Treatment for the Prevention of Bare-Metal Stent Restenosis in Diabetic Patients
- (2013) Spyridon Deftereos et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Drug-coated balloon therapy in coronary and peripheral artery disease
- (2013) Robert A. Byrne et al. Nature Reviews Cardiology
- Emerging technologies: polymer-free phospholipid encapsulated sirolimus nanocarriers for the controlled release of drug from a stent-plus-balloon or a stand-alone balloon catheter
- (2013) Pedro A. Lemos et al. EuroIntervention
- A multicenter randomized comparison of drug-eluting balloon plus bare-metal stent versus bare-metal stent versus drug-eluting stent in bifurcation lesions treated with a single-stenting technique: Six-month angiographic and 12-month clinical results of th
- (2012) Pieter R. Stella et al. CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS
- Comparison of Everolimus-Eluting and Sirolimus-Eluting Coronary Stents
- (2012) Takeshi Kimura et al. CIRCULATION
- Inflammation and Vascular Injury
- (2012) Daniel I. Simon CIRCULATION JOURNAL
- A Randomized Multicenter Study Comparing a Paclitaxel Drug-Eluting Balloon With a Paclitaxel-Eluting Stent in Small Coronary Vessels
- (2012) Azeem Latib et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- A Randomized Controlled Trial in Second-Generation Zotarolimus-Eluting Resolute Stents Versus Everolimus-Eluting Xience V Stents in Real-World Patients
- (2012) Clemens von Birgelen et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Stent thrombosis with drug-eluting and bare-metal stents: evidence from a comprehensive network meta-analysis
- (2012) Tullio Palmerini et al. LANCET
- Everolimus-eluting stent versus bare-metal stent in ST-segment elevation myocardial infarction (EXAMINATION): 1 year results of a randomised controlled trial
- (2012) Manel Sabate et al. LANCET
- Paclitaxel-eluting balloons, paclitaxel-eluting stents, and balloon angioplasty in patients with restenosis after implantation of a drug-eluting stent (ISAR-DESIRE 3): a randomised, open-label trial
- (2012) Robert A Byrne et al. LANCET
- Vascular healing in drug-eluting stents: differential drug-associated response of limus-eluting stents in a preclinical model of stent implantation
- (2012) Kristin Steigerwald et al. EuroIntervention
- Randomized comparison of cost-saving and effectiveness of oral rapamycin plus bare-metal stents with drug-eluting stents: Three-year outcome from the randomized oral rapamycin in Argentina (ORAR) III trial
- (2011) Alfredo E. Rodriguez et al. CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS
- Stent Thrombogenicity Early in High-Risk Interventional Settings Is Driven by Stent Design and Deployment and Protected by Polymer-Drug Coatings
- (2011) Kumaran Kolandaivelu et al. CIRCULATION
- EXCELLA™ First-in-Man (FIM) study: safety and efficacy of novolimus-eluting stent in de novo coronary lesions
- (2011) Ribamar Costa et al. EuroIntervention
- Efficacy of Cilostazol in reducing restenosis in patients undergoing contemporary stent based PCI: a meta-analysis of randomised controlled trials
- (2011) Umesh Tamhane et al. EuroIntervention
- Paclitaxel-coated balloon versus drug-eluting stent during PCI of small coronary vessels, a prospective randomised clinical trial. The PICCOLETO Study
- (2010) B. Cortese et al. HEART
- Preventing Restenosis after Implantation of Bare Stents with Oral Rapamycin: A Randomized Angiographic and Intravascular Ultrasound Study with a 5-Year Clinical Follow-Up
- (2009) Carmelo Cernigliaro et al. CARDIOLOGY
- Paclitaxel-Coated Balloon Catheter Versus Paclitaxel-Coated Stent for the Treatment of Coronary In-Stent Restenosis
- (2009) Martin Unverdorben et al. CIRCULATION
- Efficacy and safety of pioglitazone in patients with ST elevation myocardial infarction treated with primary stent implantation
- (2009) H Kaneda et al. HEART
- A Prospective, Multicenter, Randomized Trial to Assess Efficacy of Pioglitazone on In-Stent Neointimal Suppression in Type 2 Diabetes
- (2009) Tsutomu Takagi et al. JACC-Cardiovascular Interventions
- Long-Term Risk of Adverse Outcomes and New Malignancies in Patients Treated With Oral Sirolimus for Prevention of Restenosis
- (2009) Sebastian Kufner et al. JACC-Cardiovascular Interventions
- Durability of Antirestenotic Efficacy in Drug-Eluting Stents With and Without Permanent Polymer
- (2009) Robert A. Byrne et al. JACC-Cardiovascular Interventions
- Two year follow-up after treatment of coronary in-stent restenosis with a paclitaxel-coated balloon catheter
- (2008) Bruno Scheller et al. Clinical Research in Cardiology
- Endothelial Cell Recovery Between Comparator Polymer-Based Drug-Eluting Stents
- (2008) Michael Joner et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Drug-Eluting Stenting Followed by Cilostazol Treatment Reduces Late Restenosis in Patients With Diabetes Mellitus
- (2008) Seung-Whan Lee et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Effects of succinobucol (AGI-1067) after an acute coronary syndrome: a randomised, double-blind, placebo-controlled trial
- (2008) Jean-Claude Tardif et al. LANCET
- TZDs and Bone: A Review of the Recent Clinical Evidence
- (2008) Ann V. Schwartz PPAR Research
- Pioglitazone attenuates neointimal thickening via suppression of the early inflammatory response in a porcine coronary after stenting
- (2007) Takatoshi Kasai et al. ATHEROSCLEROSIS
- Randomized Comparison of Cilostazol vs Clopidogrel After Drug-Eluting Stenting in Diabetic Patients
- (2007) Youngkeun Ahn et al. CIRCULATION JOURNAL
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started